¼¼°è ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå : ¹Ù´Ã À¯Çüº°, Àü´Þ ºÎÀ§º°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° »ê¾÷ ºÐ¼® - ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø(2023³â-2030³â)
Disposable Asepsis Safe Injection Needle Market, By Needle Type, By Delivery Site, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
»óǰÄÚµå : 1419060
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 322 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,520,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,467,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,858,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå ±Ô¸ð´Â 2022³â 18¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í 2023³âºÎÅÍ 2030³â±îÁö º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 10.2%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå - ½ÃÀå ¿ªÇÐ

Ç÷¾× ¸Å°³ ¹ÙÀÌ·¯½º(BBV) °¨¿°ÀÇ °¡´É¼ºÀ» ÁÙÀ̱â À§ÇØ °Ç°­ °ü¸® ±ÔÁ¦ ±â°üÀÌ ¾ÈÀüÇÑ Áֻ縦 ¼öÇàÇϵµ·Ï ÃßÁøÇÏ´Â ÀǽÄÀÌ ³ô¾Æ ½ÃÀå ¼ö¿ä¸¦ °ßÀÎ

ÀáÀçÀûÀÎ Ç÷¾× ¸Å°³ ¹ÙÀÌ·¯½º(BBV) °¨¿°ÀÇ °¨¼Ò¸¦ ¸ñÇ¥·Î ÇÏ¿© ¾ÈÀüÇÑ Áֻ縦 ½Ç½ÃÇϱâ À§ÇØ °Ç°­ °ü¸® ±ÔÁ¦±â°üÀÌ ÃßÁøÇÏ´Â ÀǽÄÀÇ °íÁ¶°¡ ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, ¼¼°èº¸°Ç±â±¸(WHO)´Â 2012³â 2¿ù¿¡ ¾ÈÀüÇÏÁö ¾ÊÀº Áֻ簡 ¿¹»ó 130¸¸ ¸íÀÇ Á¶±â »ç¸ÁÀ» ÀÏÀ¸ÄÑ ¿¬°£ 5¾ï 3,500¸¸ ´Þ·¯ÀÇ Á÷Á¢ ÀÇ·áºñ°¡ ¹ß»ýÇß´Ù°í º¸°íÇß½À´Ï´Ù. ¶ÇÇÑ ½ÅÈï°æÁ¦±¹¿¡¼­´Â ¾ÈÀüÇÏÁö ¾ÊÀº ÁÖ»ç ½À°üÀÌ CÇü °£¿°ÀÇ ¹ßº´¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇàÀ§´Â BÇü °£¿° ¹ÙÀÌ·¯½º, CÇü °£¿° ¹ÙÀÌ·¯½º, Àΰ£ ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º(HIV) µî Ç÷¾× ¸Å°³ º´¿øÃ¼ÀÇ °¨¿°µµ ÃËÁøÇÕ´Ï´Ù. ½ÃÀåÀº ¾Ï, HIV/AIDS, ´ç´¢º´, °ü»óµ¿¸Æ¼º ½ÉÁúȯ, ºóÇ÷ µî Áúº´ÀÇ À¯º´·ü »ó½Â¿¡ ÀÇÇØ ´õ¿í Àڱصǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼ö¼ú °Ç¼ö Áõ°¡, ±ä±Þ »ç·Ê, ¼öÇ÷ÀÇ ³ôÀº ¼ö¿ä°¡ ½ÃÀå¿¡ À¯¸®ÇÑ ¼ºÀå Àü¸ÁÀ» Á¦½ÃÇϰí ÀÖ½À´Ï´Ù.

ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀåÀº ¹Ù´Ã À¯Çü, Àü´Þ ºÎÀ§, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº ¹Ù´Ã À¯Çü¿¡ µû¶ó µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. Áï, ±âÁ¸ÀÇ ÁÖ»ç ¹Ù´Ã°ú ¾ÈÀü ÁÖ»ç ¹Ù´ÃÀÔ´Ï´Ù. ¾ÈÀü ¹Ù´ÃÀº ¿ì¹ßÀûÀÎ ¹Ù´Ã Â±â ºÎ»óÀ» ÃÖ¼ÒÈ­ÇÏ°í ±³Â÷ ¿À¿°À» ¹æÁöÇϵµ·Ï ¼³°èµÈ °í±Þ ¾ÈÀü ±â´ÉÀ¸·Î ½ÃÀå¿¡¼­ °¡Àå ¿ìÀ§¸¦ Â÷ÁöÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹Ù´Ã¿¡´Â »ç¿ë ÈÄ¿¡ ¹Ù´Ã ³¡À» ÀÚµ¿À¸·Î Ä¿¹öÇÏ´Â ¼ö³³½ÄÀ̳ª ½Çµå ¼³°è µîÀÇ ±â±¸°¡ ³»ÀåµÇ¾î ÀÖ¾î ÀÇ·á Á¾»çÀÚ³ª ȯÀÚ°¡ ½Ç¼ö·Î ¹Ù´ÃÀ» Âñ¸®´Â À§ÇèÀ» Àú°¨Çϰí ÀÖ½À´Ï´Ù. ¾ÈÀü ÇÁ·ÎÅäÄÝÀ̳ª º¸´Ù ¾ÈÀüÇÑ ÀÇ·á±â±âÀÇ »ç¿ëÀ» Á¦Ã¢ÇÏ´Â ±ÔÁ¦°¡ Áß½ÃµÇ°Ô µÊÀ¸·Î½á, ´Ù¾çÇÑ ÇコÄɾî ÇöÀå¿¡¼­ ¾ÈÀü ÁÖ»ç ¹Ù´ÃÀÌ ³Î¸® ä¿ëµÇ°í, ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù.

ÀÌ ½ÃÀåÀº Àü´Þ ºÎÀ§¿¡ µû¶ó 5 °¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù : Çdz», ÇÇÇÏ, Á¤¸Æ ³», ±ÙÀ° ³», º¹°­ ³». Àü´Þ ºÎÀ§ Áß ±ÙÀ°³» ÁÖ»ç´Â ¹é½Å, ƯÁ¤ ¾à¹° ¹× Ä¡·áÀÇ Åõ¿©¿¡ ³Î¸® »ç¿ëµÇ±â ¶§¹®¿¡ ½ÃÀå¿¡¼­ Å« ÀÌÁ¡À» Â÷ÁöÇÕ´Ï´Ù. ±ÙÀ°³» ÁÖ»ç´Â ±ÙÀ° Á¶Á÷ ³»¿¡ ¾àÁ¦¸¦ Åõ¿©ÇÏ´Â °ÍÀ¸·Î, ´Ù¸¥ Àü´Þ ºÎÀ§¿¡ ºñÇØ Èí¼ö°¡ ºü¸£°í È¿´Éµµ ³ô½À´Ï´Ù. ÀÌ ¹æ¹ýÀº ÀϹÝÀûÀ¸·Î ¿¹¹æ Á¢Á¾, ƯÁ¤ Ç×»ýÁ¦ ¹× Ç÷·ù¿¡ ½Å¼ÓÇÑ Èí¼ö¸¦ ÇÊ¿ä·ÎÇÏ´Â ¾à¹°¿¡ »ç¿ëµÇ¸ç ±ÙÀ° ³» Áֻ縦 ´Ù¾çÇÑ °Ç°­ °ü¸® ȯ°æ¿¡¼­ Ź¿ùÇÑ ¼±ÅÃÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖÀ¸¸ç ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå¿¡¼­ ¿ìÀ§¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

Áö¿ªÀûÀ¸·Î, ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °¢ Áö¿ªÀ¸·Î ÆÛÁ® ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ Á¦°øÇÏ´Â ±¹°¡¿¡ ÀÇÇØ ´õ ³ª´¹´Ï´Ù.

ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå - °æÀï ±¸µµ :

ÀÌ ½ÃÀå¿¡¼­ ±â¾÷Àº ¾÷°è ¼ö¿ä¸¦ ÃæÁ·Çϰí Á¦Ç°ÀÇ È¿À²¼ºÀ» º¸ÀåÇϱâ À§ÇØ Àü·«Àû ¹æ¹ýÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¾ÈÀü¼ºÀ» ÃÖ¿ì¼±À¸·Î ÇÏ°í ¹Ù´Ã Â±â ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϰí ȯÀÚÀÇ ÄèÀû¼ºÀ» ³ôÀÌ´Â ÁÖ»ç ¹Ù´Ã µðÀÚÀÎÀÇ Çõ½ÅÀ» ¸ñÇ¥·Î ÇÑ ¿¬±¸°³¹ß¿¡´Â ¸¹Àº ÅõÀÚ°¡ ÇÒ´çµÇ°í ÀÖ½À´Ï´Ù. ÷´Ü Á¦Á¶ ±â¼úÀ» äÅÃÇÏ´Â °ÍÀº ¾ö°ÝÇÑ ¸ê±Õ ±âÁØÀ» ÁؼöÇϰí À¯Åë ¹× »ç¿ëÁßÀÎ Á¦Ç°ÀÇ ³»±¸¼ºÀ» º¸ÀåÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. °¢ ȸ»ç´Â ¶ÇÇÑ Æ¯Á¤ ÀÇ·á ÀýÂ÷ ¹× °³º° ȯÀÚÀÇ ¿ä±¸¿¡ ¸Â´Â ´Ù¾çÇÑ ¹Ù´ÃÀ» Á¦°øÇϱâ À§ÇØ Á¦Ç° Æ÷Æ®Æú¸®¿ÀÀÇ È®´ë¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á±â°ü°úÀÇ Á¦ÈÞ ¹× ±ÔÁ¦±âÁØ Áؼö´Â ¸Å¿ì Áß¿äÇϸç ÀÇ·á±â°ü°ú ȯÀÚÀÇ ½Å·Ú¸¦ Ű¿ì´Â µ¿½Ã¿¡ ¾ÈÀü±âÁØ Áؼö¸¦ º¸ÀåÇÕ´Ï´Ù. °Ô´Ù°¡ ¾÷°è µ¿Çâ¿¡ ¸ÂÃß¾î ģȯ°æ ¼ÒÀ縦 ÀÌ¿ëÇÏ¿© Áö¼Ó°¡´ÉÇÑ Á¦Á¶¹æ¹ýÀ» ½Ç½ÃÇÏ´Â °ÍÀÌ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ÀÌ ³ë·ÂÀº ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå¿¡¼­ ȯ°æ ¹ßÀÚ±¹À» ÁÙÀ̰í Ã¥ÀÓÀÖ´Â Æó±â ¹æ¹ýÀ» Á¦¾ÈÇÏ´Â °ÍÀ» ¸ñÇ¥·ÎÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´ÃÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã »ê¾÷ Á¶»ç

Á¦5Àå ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå »óȲ

Á¦7Àå ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå : ¹Ù´Ã À¯Çüº°

Á¦8Àå ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå : Àü´Þ ºÎÀ§º°

Á¦9Àå ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã ½ÃÀå : Áö¿ª

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÀÏȸ¿ë ¹«±Õ ¾ÈÀü ÁÖ»ç ¹Ù´Ã »ê¾÷

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Disposable Asepsis Safe Injection Needle Market size was valued at USD 1,810.00 Million in 2022, expanding at a CAGR of 10.2% from 2023 to 2030.

The Disposable Asepsis Safe Injection Needle is a sterile, single-use needle designed to prioritize patient safety and prevent infections. Crafted from materials meeting stringent sterilization standards, these needles minimize contamination risks and disease transmission during medical procedures. Tailored for healthcare facilities, clinics, and hospitals, the market provides various needle sizes and types for different medical applications, such as vaccinations, drug administration, and blood sample collection.

Disposable Asepsis Safe Injection Needle Market- Market Dynamics

Escalating awareness promoted by healthcare regulatory bodies to enforce safe injection practices, aiming to reduce potential blood-borne virus (BBV) infections to propel market demand

Elevated awareness promoted by healthcare regulatory bodies to enforce safe injection practices, aiming to reduce potential blood-borne virus (BBV) infections, is expected to drive growth in the disposable asepsis safe injection needle market. For instance, the World Health Organization (WHO) reported that unsafe injections caused an estimated 1.3 million premature deaths and incurred annual direct medical costs of US$ 535 million in February 2012. Additionally, unsafe injection practices significantly contribute to hepatitis C cases in developing economies. These practices also facilitate the transmission of blood-borne pathogens like hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV). The market is further stimulated by the rising prevalence of diseases like cancer, HIV/AIDS, diabetes, coronary heart disease, and anemia. Moreover, the increasing number of surgeries, emergency cases, and the high demand for blood transfusions are presenting lucrative growth prospects in the market.

Disposable Asepsis Safe Injection Needle Market- Key Insights

Disposable Asepsis Safe Injection Needle Market- Segmentation Analysis:

The Global Disposable Asepsis Safe Injection Needle Market is segmented on the basis of Needle Type, Delivery Site, End User, and Region.

The market is divided into two categories based on Needle Type: Conventional and Safety Needles. Safety needles stand out as the most dominant in the market due to their advanced safety features designed to minimize accidental needlestick injuries and prevent cross-contamination. These needles incorporate mechanisms like retractable or shielded designs that automatically cover the needle tip after use, reducing the risk of accidental pricks for healthcare professionals and patients. The increased emphasis on safety protocols and regulations advocating for the use of safer medical devices has propelled the widespread adoption of safety needles across various healthcare settings, significantly impacting the disposable asepsis safe injection needle market.

The market is divided into five categories based on Delivery Site: Intradermal, Subcutaneous, Intravenous, Intramuscular and Intraperitoneal. Among the delivery sites, intramuscular injections hold significant dominance in the market owing to their widespread use in administering vaccines, certain medications, and therapies. Intramuscular injections involve delivering medication into the muscle tissue, offering quicker absorption and efficacy compared to other delivery sites. This method is commonly employed for immunizations, certain antibiotics, and medications requiring rapid absorption into the bloodstream, making intramuscular injections a prominent choice across diverse healthcare settings, contributing to their dominance in the disposable asepsis safe injection needle market.

Disposable Asepsis Safe Injection Needle Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Disposable Asepsis Safe Injection Needle Market- Competitive Landscape:

Within this market, companies employ strategic methodologies to meet industry demands and guarantee the effectiveness of their products. Substantial investments are allocated to research and development aimed at innovating needle designs that prioritize safety, minimize needlestick injuries, and enhance patient comfort. Employing advanced manufacturing techniques is crucial to comply with strict sterilization criteria, ensuring the durability of products during distribution and usage. Comapnies also concentrate on broadening their product portfolios to offer a diverse array of needles tailored to specific medical procedures and individual patient requirements. Additionally, partnerships with healthcare organizations and adherence to regulatory standards are pivotal, fostering trust among healthcare professionals and patients alike while ensuring compliance with safety benchmarks. Moreover, there's a growing emphasis on utilizing eco-friendly materials and implementing sustainable manufacturing practices in line with industry trends. This effort aims to reduce the environmental footprint and advocate for responsible disposal practices within the disposable asepsis safe injection needle market.

Recent Developments:

In May 2022, BD and Mitsubishi Gas Chemical signed a letter of intent (LOI) to explore a partnership agreement, aiming to advance biologic drug delivery through new innovative methods.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DISPOSABLE ASEPSIS SAFE INJECTION NEEDLE MARKET KEY PLAYERS

GLOBAL DISPOSABLE ASEPSIS SAFE INJECTION NEEDLE MARKET, BY NEEDLE TYPE

GLOBAL DISPOSABLE ASEPSIS SAFE INJECTION NEEDLE MARKET, BY DELIVERY SITE

GLOBAL DISPOSABLE ASEPSIS SAFE INJECTION NEEDLE MARKET, BY END USER

GLOBAL DISPOSABLE ASEPSIS SAFE INJECTION NEEDLE MARKET, BY REGION

Table of Contents

1. Disposable Asepsis Safe Injection Needle Market Overview

2. Executive Summary

3. Disposable Asepsis Safe Injection Needle Key Market Trends

4. Disposable Asepsis Safe Injection Needle Industry Study

5. Disposable Asepsis Safe Injection Needle Market: COVID-19 Impact Analysis

6. Disposable Asepsis Safe Injection Needle Market Landscape

7. Disposable Asepsis Safe Injection Needle Market - By Needle Type

8. Disposable Asepsis Safe Injection Needle Market - By Delivery Site

9. Disposable Asepsis Safe Injection Needle Market - By End User

10. Disposable Asepsis Safe Injection Needle Market- By Geography

11. Key Vendor Analysis- Disposable Asepsis Safe Injection Needle Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â